我武生物 (300357.SZ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	1.1B	1.1B	925.4M	848.2M	896.0M
Cost of Revenue	50.6M	50.6M	44.8M	40.2M	41.3M
Gross Profit	1.0B	1.0B	880.6M	808.0M	854.7M
Operating Expenses
R&D Expense	112.4M	117.1M	119.9M	112.2M	106.0M
SG&A Expense	—	—	—	—	—
General & Admin Expense	86.1M	81.3M	73.2M	62.1M	47.8M
Selling & Marketing Expense	401.0M	397.8M	361.4M	323.2M	311.8M
Other Expenses	—	—	—	—	—
Total Operating Expenses	590.1M	584.9M	533.8M	473.7M	446.0M
Cost and Expenses	640.7M	635.5M	578.6M	513.9M	487.2M
Operating Income (EBIT)	486.7M	438.4M	369.1M	345.0M	396.2M
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	—	—	—	—	—
Net Interest Income	—	—	—	—	—
Other Non-Op Income/Expense	—	—	—	—	—
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	480.5M	432.7M	365.1M	346.0M	398.7M
Income Tax Expense	67.5M	64.6M	60.7M	50.4M	63.0M
Bottom Line
Net Income	425.8M	380.9M	317.8M	310.2M	348.8M
Earnings from Cont. Ops	413.1M	368.1M	304.3M	295.5M	335.7M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	425.8M	380.9M	317.8M	310.2M	348.8M
Per Share
Basic EPS	CN¥0.81	CN¥0.73	CN¥0.61	CN¥0.59	CN¥0.67
Diluted EPS	CN¥0.81	CN¥0.73	CN¥0.61	CN¥0.59	CN¥0.67
Revenue Per Share	CN¥2.08	CN¥2.03	CN¥1.77	CN¥1.62	CN¥1.71
Shares
Basic Shares Outstanding	523.6M	523.6M	523.6M	523.6M	523.6M
Diluted Shares Outstanding	523.6M	523.6M	523.6M	523.6M	523.6M
Profitability Metrics
EBITDA	—	490.1M	415.0M	377.4M	418.5M
D&A	—	51.7M	45.9M	32.4M	22.3M
EBIT	—	—	—	—	—

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026